Search research articles
Contact Us
Filters
Showing results (301-310 of 337) with videos related to
Page
of 34
Sort By:
Nature Communications
|
July 26, 2022
T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
Fanlin Li, Huihui Zhang, Wanting Wang, et al.
The Journal of Clinical Investigation
|
January 14, 2025
Sequential intranasal booster triggers class switching from intramuscularly primed IgG to mucosal IgA against SARS-CoV-2
Yifan Lin, Xuejiao Liao, Xuezhi Cao, et al.
Nature Communications
|
March 10, 2019
The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy
Gui-Zhen Wang, Li Zhang, Xin-Chun Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 21, 2025
Tumor-targeted delivery of CXCL10 by mesenchymal stromal cells potentiates adoptive T cell therapy to treat solid tumors
Jeong Ho Yoon, Gyu-Bum Yeon, Hojae Lee, et al.
Nature Nanotechnology
|
October 27, 2022
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration
Kaiting Yang, Wenbo Han, Xiaomin Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2024
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
Jason Bugno, Liangliang Wang, Xianbin Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2014
Commensal bacteria protect against food allergen sensitization
Andrew T Stefka, Taylor Feehley, Prabhanshu Tripathi, et al.
Cancer Cell
|
December 18, 2020
MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway
Junhong Guan, Changzheng Lu, Qihuang Jin, et al.
Oncoimmunology
|
May 4, 2018
A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice
Jae-Hyeog Choi, Ki Hyang Kim, Kug-Hwan Roh, et al.
Nature Communications
|
February 25, 2021
Proteolysis-targeting chimera against BCL-X<sub>L</sub> destroys tumor-infiltrating regulatory T cells
Ryan Kolb, Umasankar De, Sajid Khan, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 337) with videos related to
Sort By:
Page
of 34
Nature Communications
|
July 26, 2022
T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
Fanlin Li, Huihui Zhang, Wanting Wang, et al.
The Journal of Clinical Investigation
|
January 14, 2025
Sequential intranasal booster triggers class switching from intramuscularly primed IgG to mucosal IgA against SARS-CoV-2
Yifan Lin, Xuejiao Liao, Xuezhi Cao, et al.
Nature Communications
|
March 10, 2019
The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy
Gui-Zhen Wang, Li Zhang, Xin-Chun Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 21, 2025
Tumor-targeted delivery of CXCL10 by mesenchymal stromal cells potentiates adoptive T cell therapy to treat solid tumors
Jeong Ho Yoon, Gyu-Bum Yeon, Hojae Lee, et al.
Nature Nanotechnology
|
October 27, 2022
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration
Kaiting Yang, Wenbo Han, Xiaomin Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2024
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
Jason Bugno, Liangliang Wang, Xianbin Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2014
Commensal bacteria protect against food allergen sensitization
Andrew T Stefka, Taylor Feehley, Prabhanshu Tripathi, et al.
Cancer Cell
|
December 18, 2020
MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway
Junhong Guan, Changzheng Lu, Qihuang Jin, et al.
Oncoimmunology
|
May 4, 2018
A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice
Jae-Hyeog Choi, Ki Hyang Kim, Kug-Hwan Roh, et al.
Nature Communications
|
February 25, 2021
Proteolysis-targeting chimera against BCL-X<sub>L</sub> destroys tumor-infiltrating regulatory T cells
Ryan Kolb, Umasankar De, Sajid Khan, et al.
Page
of 34